Paragangliomas Active Not Recruiting Phase 2 Trials for Sunitinib (DB01268)

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

IndicationStatusPhase
DBCOND0051744 (Paragangliomas)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00843037Study Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaTreatment